ACM
ADAR1 Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.2M | Sell |
259,659
-79,976
| -24% | -$3.45M | 1.72% | 12 |
|
2025
Q1 | $11.7M | Sell |
339,635
-339,222
| -50% | -$11.7M | 2.18% | 10 |
|
2024
Q4 | $18.6M | Sell |
678,857
-769,613
| -53% | -$21.1M | 3.72% | 7 |
|
2024
Q3 | $36.9M | Buy |
1,448,470
+183,900
| +15% | +$4.68M | 6% | 3 |
|
2024
Q2 | $32M | Buy |
1,264,570
+714,766
| +130% | +$18.1M | 6.05% | 5 |
|
2024
Q1 | $17M | Buy |
549,804
+364,667
| +197% | +$11.3M | 3.86% | 8 |
|
2023
Q4 | $7.47M | Buy |
+185,137
| New | +$7.47M | 2.67% | 6 |
|